PlainRecalls
FDA Devices Critical Class I Terminated

SpF PLUS-Mini (60 ¿A/W) Implantable Spinal Fusion Stimulator SpF PLUS-Mini Implantable Fusion Stimulators are indicated as a spinal fusion adjunct to increase the probability of fusion success in 1 or 2 levels

Reported: November 7, 2018 Initiated: February 19, 2018 #Z-0287-2019

Product Description

SpF PLUS-Mini (60 ¿A/W) Implantable Spinal Fusion Stimulator SpF PLUS-Mini Implantable Fusion Stimulators are indicated as a spinal fusion adjunct to increase the probability of fusion success in 1 or 2 levels

Reason for Recall

Lack of adequate validation and controls to ensure that product cleanliness parameters were consistently met.

Details

Recalling Firm
Zimmer Biomet, Inc.
Units Affected
4,879 units (2,982 units have been implanted and 537 have been scrapped)
Distribution
US Nationwide Distribution: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV ; and country of: Australia.
Location
Warsaw, IN

Frequently Asked Questions

What product was recalled?
SpF PLUS-Mini (60 ¿A/W) Implantable Spinal Fusion Stimulator SpF PLUS-Mini Implantable Fusion Stimulators are indicated as a spinal fusion adjunct to increase the probability of fusion success in 1 or 2 levels. Recalled by Zimmer Biomet, Inc.. Units affected: 4,879 units (2,982 units have been implanted and 537 have been scrapped).
Why was this product recalled?
Lack of adequate validation and controls to ensure that product cleanliness parameters were consistently met.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 7, 2018. Severity: Critical. Recall number: Z-0287-2019.